Literature DB >> 25970115

The "Milwaukee protocol" for treatment of human rabies is no longer valid.

Henry Wilde1, Thiravat Hemachudha.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25970115     DOI： 10.1097/INF.0000000000000641

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  5 in total

1.  Inhibition of Rabies Virus by 1,2,3,4,6-Penta-O-galloyl-β-d-Glucose Involves mTOR-Dependent Autophagy.

Authors:  Zhongzhong Tu; Wenjie Gong; Yan Zhang; Ye Feng; Yan Liu; Changchun Tu
Journal:  Viruses       Date:  2018-04-17       Impact factor: 5.818

Review 2.  The path towards effective antivirals against rabies.

Authors:  Dirk Jochmans; Johan Neyts
Journal:  Vaccine       Date:  2017-12-24       Impact factor: 3.641

3.  Potential Use of Sofosbuvir in the Prophylaxis for Rabies.

Authors:  Sandra E Reznik; Amit K Tiwari; Charles R Ashby
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810

4.  Machine Learning Identifies Cellular and Exosomal MicroRNA Signatures of Lyssavirus Infection in Human Stem Cell-Derived Neurons.

Authors:  Ryan J Farr; Nathan Godde; Christopher Cowled; Vinod Sundaramoorthy; Diane Green; Cameron Stewart; John Bingham; Carmel M O'Brien; Megan Dearnley
Journal:  Front Cell Infect Microbiol       Date:  2021-12-24       Impact factor: 5.293

5.  Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics.

Authors:  Terence Peter Scott; Louis Hendrik Nel
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.